27 U.S. Cities Where Stocks Yield 26% a Year

From Investing Daily | Ad

What’s the highest-yielding stock you’ve ever owned? The dividends for these stocks have risen so fast over the years that they’re now yielding us an average of 26%!

When you start getting paid 26% on your money, your financial problems tend to pretty much evaporate.

Get in on the action here.

ALT Insider Trading (Altimmune)

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 3.14%

Insider Buying (Last 12 Months): $13,400.00

Insider Selling (Last 12 Months): $1,618,153.50

Altimmune Insider Trading History Chart

Altimmune Share Price & Price History

^$17.36

▲ +3.59 (26.07%)

As of 08/12/2022 01:00 AM ET

Days: 30 | 90 | 365

The Safest Option in Trades!

From Tradewins | Ad

If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!

Click here now!

Altimmune Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/12/2022	Vipin K Garg	CEO	Sell	15,000	$15.06	$225,900.00	259,804
7/5/2022	M Scot Roberts	Insider	Sell	10,182	$12.00	$122,184.00	8,305
7/1/2022	M Scot Roberts	Insider	Sell	26,982	$12.00	$323,784.00	17,700
6/29/2022	M Scot Roberts	Insider	Sell	5,462	$12.00	$65,544.00	17,700
6/27/2022	Diane Jorkasky	Director	Sell	17,610	$11.75	$206,917.50
6/27/2022	M Scot Roberts	Insider	Sell	37,352	$12.00	$448,224.00	17,700
6/15/2022	David Drutz	Director	Buy	1,000	$8.00	$8,000.00	20,012
5/24/2022	David Drutz	Director	Buy	1,200	$4.50	$5,400.00	19,012
2/28/2022	Matthew Scott Harris	Insider	Sell	30,000	$7.52	$225,600.00
3/1/2021	Philip Hodges	Director	Sell	6,000	$16.08	$96,480.00	8,731
12/10/2020	Klaus Schafer	Director	Buy	2,000	$11.99	$23,980.00	8,900
11/30/2020	Philip Hodges	Director	Sell	2,500	$12.00	$30,000.00	14,731
11/12/2020	Klaus Schafer	Director	Sell	10,150	$9.91	$100,586.50	6,900
6/15/2020	Venrock Healthcare Capital Par	Major Shareholder	Buy	1,500,000	$7.54	$11,310,000.00
5/28/2020	Venrock Healthcare Capital Par	Major Shareholder	Buy	201,474	$8.72	$1,756,853.28
5/26/2020	Venrock Healthcare Capital Par	Major Shareholder	Buy	700,000	$9.34	$6,538,000.00
5/14/2020	Pharmaceutical Holdin Velocity	Major Shareholder	Sell	169,378	$4.81	$814,708.18
9/5/2019	Vipin K Garg	CEO	Buy	20,000	$2.10	$42,000.00	342,907

The Safest Option in Trades!

From Tradewins | Ad

Click here now!

SEC Filings (Institutional Ownership Changes) for Altimmune (NASDAQ:ALT)

88.00% of Altimmune stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Altimmune Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
8/13/2022	Renaissance Technologies LLC	665,400	$7.79M	0.0%	+71.2%	1.540%
8/12/2022	Northern Trust Corp	101,789	$1.19M	0.0%	-71.7%	0.236%
8/12/2022	ClariVest Asset Management LLC	44,600	$0.52M	0.0%	N/A	0.103%
8/12/2022	CI Investments Inc.	68,400	$0.80M	0.0%	N/A	0.158%
8/11/2022	Cetera Advisors LLC	17,100	$0.20M	0.0%	-7.6%	0.040%
8/11/2022	DCF Advisers LLC	335,180	$3.92M	2.3%	+6.1%	0.776%
8/11/2022	King Wealth	10,000	$0.12M	0.0%	N/A	0.023%
8/11/2022	Platinum Investment Management Ltd.	56,863	$0.67M	0.0%	N/A	0.132%
8/11/2022	Alps Advisors Inc.	25,637	$0.30M	0.0%	-37.2%	0.059%
8/11/2022	JPMorgan Chase & Co.	160,573	$1.88M	0.0%	-47.8%	0.372%
8/8/2022	Walleye Capital LLC	134,993	$1.58M	0.0%	-36.2%	0.312%
8/2/2022	Jennison Associates LLC	109,464	$1.28M	0.0%	N/A	0.253%
8/1/2022	Chartwell Investment Partners LLC	53,294	$0.62M	0.0%	N/A	0.123%
8/1/2022	Timelo Investment Management Inc.	187,529	$2.19M	2.0%	N/A	0.434%
7/29/2022	SG Americas Securities LLC	13,487	$0.16M	0.0%	N/A	0.031%
7/27/2022	Emfo LLC	5,000	$44K	0.0%	N/A	0.012%
7/19/2022	Eagle Ridge Investment Management	10,373	$0.12M	0.0%	N/A	0.024%
7/13/2022	Beirne Wealth Consulting Services LLC	284,647	$3.33M	2.2%	+54.8%	0.659%
7/12/2022	FNY Investment Advisers LLC	2,730	$31K	0.0%	N/A	0.006%
6/30/2022	Amalgamated Bank	4,793	$29K	0.0%	N/A	0.011%
6/7/2022	Bank of America Corp DE	22,838	$0.14M	0.0%	-89.9%	0.053%
5/27/2022	Walleye Capital LLC	211,753	$1.29M	0.0%	+192.9%	0.490%
5/18/2022	BNP Paribas Arbitrage SA	8,836	$54K	0.0%	-85.2%	0.020%
5/17/2022	Walleye Capital LLC	211,753	$1.29M	0.0%	+192.9%	0.490%
5/17/2022	Dynamic Technology Lab Private Ltd	17,355	$0.11M	0.0%	N/A	0.040%
5/16/2022	California State Teachers Retirement System	16,943	$0.10M	0.0%	-20.9%	0.039%
5/16/2022	Goldman Sachs Group Inc.	728,869	$4.44M	0.0%	+50.2%	1.686%
5/16/2022	PDT Partners LLC	124,377	$0.76M	0.1%	+4.6%	0.288%
5/16/2022	Woodline Partners LP	846,618	$5.16M	0.1%	+36.4%	1.959%
5/16/2022	State Street Corp	691,141	$4.21M	0.0%	-84.4%	1.599%
5/16/2022	Engineers Gate Manager LP	14,365	$87K	0.0%	N/A	0.033%
5/16/2022	Graham Capital Management L.P.	10,345	$63K	0.0%	N/A	0.024%
5/13/2022	Renaissance Technologies LLC	388,700	$2.37M	0.0%	+481.9%	0.899%
5/13/2022	Northern Trust Corp	360,127	$2.19M	0.0%	-4.3%	0.833%
5/13/2022	Charles Schwab Investment Management Inc.	104,222	$0.64M	0.0%	+3.4%	0.241%
5/13/2022	DCF Advisers LLC	316,000	$1.92M	0.8%	+12.6%	0.731%
5/13/2022	XTX Topco Ltd	19,665	$0.12M	0.1%	+33.2%	0.045%
5/13/2022	Parkman Healthcare Partners LLC	309,586	$1.89M	0.6%	+17.5%	0.716%
5/13/2022	Vanguard Group Inc.	1,816,915	$11.07M	0.0%	+4.8%	4.204%
5/13/2022	Canada Pension Plan Investment Board	182,000	$1.11M	0.0%	N/A	0.421%
5/13/2022	Dimensional Fund Advisors LP	72,702	$0.44M	0.0%	-7.4%	0.168%
5/12/2022	BlackRock Inc.	2,936,324	$17.88M	0.0%	-0.7%	6.793%
5/12/2022	MetLife Investment Management LLC	21,184	$0.13M	0.0%	+65.5%	0.049%
5/12/2022	Citigroup Inc.	790,127	$4.81M	0.0%	-25.9%	1.828%
5/12/2022	Cetera Advisors LLC	18,500	$0.11M	0.0%	N/A	0.043%
5/11/2022	Bank of New York Mellon Corp	197,247	$1.20M	0.0%	-1.5%	0.456%
5/11/2022	JPMorgan Chase & Co.	307,589	$1.87M	0.0%	+65.8%	0.712%
5/11/2022	GSA Capital Partners LLP	29,483	$0.18M	0.0%	-39.8%	0.068%
5/10/2022	ProShare Advisors LLC	11,650	$71K	0.0%	-23.7%	0.027%
5/10/2022	Beirne Wealth Consulting Services LLC	183,840	$1.12M	0.6%	+34.3%	0.425%
4/27/2022	Vahanian & Associates Financial Planning Inc.	31,426	$0.19M	0.4%	N/A	0.073%
4/14/2022	AdvisorNet Financial Inc	6,089	$37K	0.0%	-58.4%	0.014%
3/3/2022	Walleye Capital LLC	72,304	$0.66M	0.0%	N/A	0.182%
2/19/2022	Woodline Partners LP	620,678	$5.69M	0.1%	+77.9%	1.562%
2/14/2022	D. E. Shaw & Co. Inc.	1,181,237	$10.82M	0.0%	+23.6%	2.972%
2/14/2022	PDT Partners LLC	118,876	$1.09M	0.1%	N/A	0.299%
2/14/2022	Point72 Hong Kong Ltd	5,396	$49K	0.0%	N/A	0.014%
2/14/2022	LMR Partners LLP	20,000	$0.18M	0.0%	-50.3%	0.050%
2/14/2022	ETF Managers Group LLC	12,067	$0.11M	0.0%	-76.8%	0.030%
2/14/2022	Nuveen Asset Management LLC	2,295,832	$19.40M	0.0%	+184.9%	5.777%
2/14/2022	GSA Capital Partners LLP	48,997	$0.45M	0.1%	N/A	0.123%
2/10/2022	Rafferty Asset Management LLC	362,943	$3.33M	0.0%	+121.2%	0.913%
2/10/2022	Citigroup Inc.	1,066,395	$9.77M	0.0%	+877.8%	2.683%
2/9/2022	BNP Paribas Arbitrage SA	59,587	$0.55M	0.0%	+538.7%	0.150%
2/9/2022	Alps Advisors Inc.	45,984	$0.42M	0.0%	-5.1%	0.116%
2/8/2022	Bank of America Corp DE	225,570	$2.07M	0.0%	+957.9%	0.568%
2/8/2022	State Board of Administration of Florida Retirement System	10,752	$98K	0.0%	-87.5%	0.027%
2/8/2022	ProShare Advisors LLC	15,277	$0.14M	0.0%	+12.6%	0.038%
2/8/2022	Northern Trust Corp	376,484	$3.45M	0.0%	-2.8%	0.947%
2/7/2022	SG Americas Securities LLC	13,565	$0.12M	0.0%	-49.7%	0.034%
2/3/2022	Beirne Wealth Consulting Services LLC	136,840	$1.26M	0.7%	+3.7%	0.344%
1/21/2022	Russell Investments Group Ltd.	27,000	$0.25M	0.0%	N/A	0.068%
12/1/2021	Braun Stacey Associates Inc.	711,818	$8.05M	0.3%	+0.4%	1.791%
11/16/2021	Schonfeld Strategic Advisors LLC	66,600	$0.75M	0.0%	N/A	0.168%
11/16/2021	Brookfield Asset Management Inc.	26,593	$0.30M	0.0%	N/A	0.067%
11/16/2021	National Asset Management Inc.	35,227	$0.40M	0.0%	-35.2%	0.089%
11/16/2021	Squarepoint Ops LLC	60,608	$0.69M	0.0%	+485.5%	0.153%
11/16/2021	Tang Capital Management LLC	1,600,000	$18.10M	3.8%	+104.2%	4.026%
11/16/2021	VR Adviser LLC	3,800,000	$42.98M	5.5%	+8.6%	9.562%
11/15/2021	Marshall Wace LLP	478,923	$5.42M	0.0%	-48.4%	1.205%
11/15/2021	Atom Investors LP	16,977	$0.19M	0.0%	N/A	0.043%
11/15/2021	Voya Investment Management LLC	81,353	$0.92M	0.0%	+535.9%	0.205%
11/15/2021	Dana Investment Advisors Inc.	20,635	$0.23M	0.0%	+33.5%	0.052%
11/12/2021	Trexquant Investment LP	18,044	$0.20M	0.0%	N/A	0.045%
11/12/2021	Parkman Healthcare Partners LLC	175,000	$1.98M	0.5%	-12.5%	0.441%
11/12/2021	The Manufacturers Life Insurance Company	21,433	$0.24M	0.0%	+14.2%	0.054%
11/12/2021	Credit Suisse AG	1,410,397	$15.95M	0.0%	-1.4%	3.552%
11/12/2021	Geode Capital Management LLC	658,852	$7.45M	0.0%	+23.0%	1.659%
11/12/2021	Connor Clark & Lunn Investment Management Ltd.	40,435	$0.46M	0.0%	N/A	0.102%
11/10/2021	Goldman Sachs Group Inc.	476,805	$5.39M	0.0%	+2,082.7%	1.201%
11/10/2021	Citigroup Inc.	109,065	$1.23M	0.0%	-60.5%	0.275%
11/10/2021	Rafferty Asset Management LLC	164,078	$1.86M	0.0%	-9.6%	0.413%
11/10/2021	Alliancebernstein L.P.	252,810	$2.86M	0.0%	+458.1%	0.637%
11/9/2021	Beirne Wealth Consulting Services LLC	131,940	$1.49M	0.9%	-1.4%	0.332%
11/9/2021	Barclays PLC	283,019	$3.20M	0.0%	+316.4%	0.713%
11/9/2021	BlackRock Inc.	2,941,790	$33.27M	0.0%	+15.0%	7.408%
11/9/2021	Principal Financial Group Inc.	113,509	$1.28M	0.0%	-1.7%	0.286%
11/8/2021	State Board of Administration of Florida Retirement System	85,759	$0.97M	0.0%	N/A	0.216%
11/4/2021	Deutsche Bank AG	22,802	$0.26M	0.0%	+18.2%	0.057%
11/2/2021	New York State Common Retirement Fund	21,648	$0.25M	0.0%	-22.1%	0.055%

Data available starting January 2016

Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatitis. It is also developing HepTcell, an immunotherapeutic product candidate, which is in Phase 2 clinical trial for patients chronically infected with the hepatitis B virus. The company was formerly known as Vaxin Inc. and changed its name to Altimmune, Inc. in September 2015. Altimmune, Inc. was founded in 1997 is headquartered in Gaithersburg, Maryland.

Today's Range

Now: $17.36

$13.79

$18.55

50 Day Range

MA: $11.04

$5.25

$17.36

52 Week Range

Now: $17.36

$3.83

$18.55

Volume

8,829,626 shs

Average Volume

1,282,898 shs

Market Capitalization

$750.30 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.48

Who are the company insiders with the largest holdings of Altimmune?: Altimmune's top insider investors include:
Vipin K Garg (CEO)
David Drutz (Director)
M Scot Roberts (Insider)
Philip Hodges (Director)
Klaus Schafer (Director)
Diane Jorkasky (Director)
Matthew Scott Harris (Insider)
Learn More about top insider investors at Altimmune.
Who are the major institutional investors of Altimmune?: Altimmune's top institutional investors include:
Renaissance Technologies LLC — 1.54%
DCF Advisers LLC — 0.78%
Beirne Wealth Consulting Services LLC — 0.66%
Timelo Investment Management Inc. — 0.43%
JPMorgan Chase & Co. — 0.37%
Walleye Capital LLC — 0.31%
Learn More about top institutional investors of Altimmune stock.
Which institutional investors are selling Altimmune stock?: Within the previous quarter, ALT stock was sold by these institutional investors:
Northern Trust Corp
JPMorgan Chase & Co.
Walleye Capital LLC
Alps Advisors Inc.
Cetera Advisors LLC
During the previous year, company insiders that have sold Altimmune company stock include:
Vipin K Garg (CEO)
David Drutz (Director)
M Scot Roberts (Insider)
Philip Hodges (Director)
Learn More investors selling Altimmune stock.
Which institutional investors are buying Altimmune stock?: In the previous quarter, ALT stock was acquired by institutional investors including:
Renaissance Technologies LLC
Timelo Investment Management Inc.
Jennison Associates LLC
Beirne Wealth Consulting Services LLC
CI Investments Inc.
Platinum Investment Management Ltd.
Chartwell Investment Partners LLC
ClariVest Asset Management LLC
Within the previous year, these company insiders have bought Altimmune stock:
Vipin K Garg (CEO)
David Drutz (Director)
Learn More investors buying Altimmune stock.

A One Stop Shop for Everything Futures Trading

From RJO Futures | Ad

Whether you're looking to learn the basics of futures or are a seasoned vet looking to hone your trading skills, our Technical Analysis Guide has everything you need to succeed in today's futures markets!

Download your FREE Technical Analysis Trading Guide Today.